Clinical features of metastatic bone disease and risk of skeletal morbidity.
about
Hyaluronan (HA) interacting proteins RHAMM and hyaluronidase impact prostate cancer cell behavior and invadopodia formation in 3D HA-based hydrogelsBisphosphonates in the adjuvant setting of breast cancer therapy--effect on survival: a systematic review and meta-analysisMechanisms of bone metastases of breast cancerA cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone lossBone Density as a Marker of Response to Radiotherapy in Bone Metastatic Lesions: A Review of the Published DataInterleukin-6: an emerging regulator of pathological painVertebral Compression Fracture Related to Pancreatic Cancer With Osteoblastic Metastasis: A Case Report and Literature ReviewUse of Animal Models in Understanding Cancer-induced Bone PainHuman isoprenoid synthase enzymes as therapeutic targetsBone metastases: When and how lung cancer interacts with boneWhere Do Bone-Targeted Agents RANK in Breast Cancer Treatment?Bone cancer pain: from mechanism to therapyBehavioral, medical imaging and histopathological features of a new rat model of bone cancer painMolecular Mechanisms of Bone Metastasis: Which Targets Came from the Bench to the Bedside?The Walker 256 Breast Cancer Cell- Induced Bone Pain Model in RatsImplications of Hypoxia in Breast Cancer Metastasis to BoneAAPT Diagnostic Criteria for Chronic Cancer Pain ConditionsA systematic review on in vitro 3D bone metastases models: A new horizon to recapitulate the native clinical scenario?Role of positron emission tomography for the monitoring of response to therapy in breast cancerChemotherapy- and irradiation-induced bone loss in adults with solid tumorsThe reliability and validity of the Iranian version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for patients with Bone Metastases: the EORTC QLQ-BM22Osteolytica: An automated image analysis software package that rapidly measures cancer-induced osteolytic lesions in in vivo models with greater reproducibility compared to other commonly used methodsDevelopment of a preclinical orthotopic xenograft model of ewing sarcoma and other human malignant bone disease using advanced in vivo imaging15-deoxy-δ12,14-prostaglandin j2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone lossConsidering renal risk while managing cancer.Treatment of osseous metastases using the Spinal Tumor Ablation with Radiofrequency (STAR) system.The endochondral bone protein CHM1 sustains an undifferentiated, invasive phenotype, promoting lung metastasis in Ewing sarcoma.Magnetic resonance-guided focused ultrasound for patients with painful bone metastases: phase III trial resultsRegulation of osteoclast structure and function by FAK family kinasesAdvancing treatment for metastatic bone cancer: consensus recommendations from the Second Cambridge Conference.Laminin-binding integrin gene copy number alterations in distinct epithelial-type cancersEffects of androgen deprivation therapy and bisphosphonate treatment on bone in patients with metastatic castration-resistant prostate cancer: results from the University of Washington Rapid Autopsy SeriesGenetic polymorphism of the OPG gene associated with breast cancer.Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumors.Emerging HIFU applications in cancer therapy.Feasibility of isometric spinal muscle training in patients with bone metastases under radiation therapy - first results of a randomized pilot trial.MR imaging of the pelvis: a guide to incidental musculoskeletal findings for abdominal radiologists.Alendronate decreases orthotopic PC-3 prostate tumor growth and metastasis to prostate-draining lymph nodes in nude mice.Safety and efficacy of radium-223 dichloride in Japanese patients with castration-resistant prostate cancer and bone metastases.Natural history of malignant bone disease in breast cancer and the use of cumulative mean functions to measure skeletal morbidity.
P2860
Q21090839-5CCCE57A-0E6E-48B0-92F7-D1B97E5FE802Q21132670-E7C24B7B-4156-40DF-AAF4-04692D705997Q24597798-CA09BDD3-300A-48C8-9A2E-530A453FB600Q24615787-50651E74-F14F-4F20-8D78-7E02BB046919Q26738637-1BB43215-18E5-4807-888D-C1A4D612C513Q26748646-839638E6-06E5-42B3-A27E-8270A46DA8A7Q26769031-199C8C4D-D2F9-4D03-ACC6-F0CAF054F32FQ26785501-26C2B99B-A56C-466F-AE0B-BF383AF7A827Q26822639-30CA77A9-8221-4383-823A-CB1D5D33E76CQ26823287-D23B7C10-BFDD-4553-BD18-432B4A832036Q26849473-8B000901-026A-4336-8AAE-8F74898E05C8Q27025262-C17856A7-B3B5-4E9C-A0E3-FB94E44E7CE8Q27317157-6C3466D0-DAA2-4E5B-8F25-F711347C7747Q28068956-43D2A392-D262-4CBD-AABB-C617529681E9Q28075980-C9064D95-A3FA-435C-B2B1-14F97839389BQ28077444-5B91FCD7-CBF0-4D61-B6CB-1B554AF8DA92Q28079708-6F81C110-B3BC-4586-9D39-40F57EDA9843Q28080089-3B336484-94D1-49B5-AB35-41D89BEA746AQ28080621-85166B69-9F41-448C-85A3-8813F88B53A2Q28084019-FCEFC9B4-6161-42E5-97B2-4E45673D2722Q28303771-953BA8CF-F7A2-4F27-8BEB-656BBBA8DCEBQ28364664-0E0F0718-38B0-4781-8994-29D1C9B44B73Q28538391-AB2492B8-D411-4CD8-88E5-244493A005BEQ28546055-2CC5713E-4BBB-43B2-8A95-57CD8B786E39Q30234338-E8FD2E49-4DB9-49DF-B391-9E6AABCFCAADQ30241914-299769A9-22ED-4152-B2A8-F2F5233934DBQ30313322-13AD5388-5B65-4AEB-B61F-8463401BAED9Q30411668-DFA21E96-7F1C-4F1E-BE1B-9F3C1BB4BE5AQ30416629-39FF05D7-B90F-4ACD-BE78-B3AAADD72982Q30438167-18E40E9E-1366-4DBF-B52D-CBEE3342B6C3Q30489312-68BDC8C0-5730-45EB-BD6E-98D515A3AD83Q30532494-E8581333-7EF6-4295-86A2-D068CB5F5504Q30534404-C8E53189-D100-464E-B08D-2C37F7F74836Q30684593-C9B782EF-E28F-4270-A209-636A8F9AFD21Q30867165-AAFDB9FB-AF02-4533-9EC4-08FFC8509E4DQ31150703-4983D23F-11C5-459C-A3E4-A165A753B4D9Q33275193-33AF8B5D-B97A-4DB7-947F-C71EE20034BDQ33326045-53903B2C-E745-4131-91F9-0AD41021515EQ33441667-017F2B7E-EFBA-492D-8DD0-516DDB32343EQ33491284-8F55A3FF-B086-4F36-8681-E0C518A04D06
P2860
Clinical features of metastatic bone disease and risk of skeletal morbidity.
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Clinical features of metastatic bone disease and risk of skeletal morbidity.
@ast
Clinical features of metastatic bone disease and risk of skeletal morbidity.
@en
Clinical features of metastatic bone disease and risk of skeletal morbidity.
@nl
type
label
Clinical features of metastatic bone disease and risk of skeletal morbidity.
@ast
Clinical features of metastatic bone disease and risk of skeletal morbidity.
@en
Clinical features of metastatic bone disease and risk of skeletal morbidity.
@nl
prefLabel
Clinical features of metastatic bone disease and risk of skeletal morbidity.
@ast
Clinical features of metastatic bone disease and risk of skeletal morbidity.
@en
Clinical features of metastatic bone disease and risk of skeletal morbidity.
@nl
P1476
Clinical features of metastatic bone disease and risk of skeletal morbidity.
@en
P2093
Robert E Coleman
P304
6243s-6249s
P356
10.1158/1078-0432.CCR-06-0931
P407
P433
P577
2006-10-01T00:00:00Z